![](/img/cover-not-exists.png)
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial
Chanan-Khan, Asher, Miller, Kena C., Musial, Laurie, Padmanabhan, Swaminathan, Yu, Jihnhee, Ailawadhi, Sikander, Sher, Taimur, Mohr, Alice, Bernstein, Zale P., Barcos, Maurice, Patel, Mehul, Iancu, DaVolume:
50
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428190902912460
Date:
January, 2009
File:
PDF, 271 KB
english, 2009